205 related articles for article (PubMed ID: 28966119)
21. Primary cultures of glomerular parietal epithelial cells or podocytes with proven origin.
Kabgani N; Grigoleit T; Schulte K; Sechi A; Sauer-Lehnen S; Tag C; Boor P; Kuppe C; Warsow G; Schordan S; Mostertz J; Chilukoti RK; Homuth G; Endlich N; Tacke F; Weiskirchen R; Fuellen G; Endlich K; Floege J; Smeets B; Moeller MJ
PLoS One; 2012; 7(4):e34907. PubMed ID: 22529955
[TBL] [Abstract][Full Text] [Related]
22. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.
Zhang J; Pippin JW; Vaughan MR; Krofft RD; Taniguchi Y; Romagnani P; Nelson PJ; Liu ZH; Shankland SJ
Nephron Exp Nephrol; 2012; 121(1-2):e23-37. PubMed ID: 23107969
[TBL] [Abstract][Full Text] [Related]
23. De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.
Zhang J; Hansen KM; Pippin JW; Chang AM; Taniguchi Y; Krofft RD; Pickering SG; Liu ZH; Abrass CK; Shankland SJ
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F571-80. PubMed ID: 22129965
[TBL] [Abstract][Full Text] [Related]
24. Activation of podocyte Notch mediates early Wt1 glomerulopathy.
Asfahani RI; Tahoun MM; Miller-Hodges EV; Bellerby J; Virasami AK; Sampson RD; Moulding D; Sebire NJ; Hohenstein P; Scambler PJ; Waters AM
Kidney Int; 2018 Apr; 93(4):903-920. PubMed ID: 29398135
[TBL] [Abstract][Full Text] [Related]
25. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis.
Guo JK; Menke AL; Gubler MC; Clarke AR; Harrison D; Hammes A; Hastie ND; Schedl A
Hum Mol Genet; 2002 Mar; 11(6):651-9. PubMed ID: 11912180
[TBL] [Abstract][Full Text] [Related]
26. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
28. Acute multiple organ failure in adult mice deleted for the developmental regulator Wt1.
Chau YY; Brownstein D; Mjoseng H; Lee WC; Buza-Vidas N; Nerlov C; Jacobsen SE; Perry P; Berry R; Thornburn A; Sexton D; Morton N; Hohenstein P; Freyer E; Samuel K; van't Hof R; Hastie N
PLoS Genet; 2011 Dec; 7(12):e1002404. PubMed ID: 22216009
[TBL] [Abstract][Full Text] [Related]
29. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.
Zhang J; Yanez D; Floege A; Lichtnekert J; Krofft RD; Liu ZH; Pippin JW; Shankland SJ
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):234-48. PubMed ID: 25143333
[TBL] [Abstract][Full Text] [Related]
30. Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms' Tumor 1 Target Genes in Podocyte Differentiation and Maintenance.
Dong L; Pietsch S; Tan Z; Perner B; Sierig R; Kruspe D; Groth M; Witzgall R; Gröne HJ; Platzer M; Englert C
J Am Soc Nephrol; 2015 Sep; 26(9):2118-28. PubMed ID: 25556170
[TBL] [Abstract][Full Text] [Related]
31. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
Hill GS; Karoui KE; Karras A; Mandet C; Van Huyen JD; Nochy D; Bruneval P
Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
[TBL] [Abstract][Full Text] [Related]
32. TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.
Kim SI; Lee SY; Wang Z; Ding Y; Haque N; Zhang J; Zhou J; Choi ME
J Am Soc Nephrol; 2014 Sep; 25(9):1966-78. PubMed ID: 24652804
[TBL] [Abstract][Full Text] [Related]
33. The Role of WT1 in Embryonic Development and Normal Organ Homeostasis.
Wilm B; Muñoz-Chapuli R
Methods Mol Biol; 2016; 1467():23-39. PubMed ID: 27417957
[TBL] [Abstract][Full Text] [Related]
34. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
[TBL] [Abstract][Full Text] [Related]
35. Role of smooth muscle protein SM22α in glomerular epithelial cell injury.
Marshall CB; Krofft RD; Blonski MJ; Kowalewska J; Logar CM; Pippin JW; Kim F; Feil R; Alpers CE; Shankland SJ
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F1026-42. PubMed ID: 21289056
[TBL] [Abstract][Full Text] [Related]
36. Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.
Roeder SS; Barnes TJ; Lee JS; Kato I; Eng DG; Kaverina NV; Sunseri MW; Daniel C; Amann K; Pippin JW; Shankland SJ
Kidney Int; 2017 Apr; 91(4):896-913. PubMed ID: 27998643
[TBL] [Abstract][Full Text] [Related]
37. Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1.
Wagner N; Wagner KD; Scholz H; Kirschner KM; Schedl A
Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R779-87. PubMed ID: 16614054
[TBL] [Abstract][Full Text] [Related]
38. Influence of bushenhuoxue on podocytes of focal segmental glomerulosclerosis mice.
Zuo C; Tan X; Jia S; Zhang M; Zhang D
J Tradit Chin Med; 2014 Oct; 34(5):591-6. PubMed ID: 25417411
[TBL] [Abstract][Full Text] [Related]
39. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.
Asano T; Niimura F; Pastan I; Fogo AB; Ichikawa I; Matsusaka T
J Am Soc Nephrol; 2005 Aug; 16(8):2257-62. PubMed ID: 15987751
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
Guo N; Guo J; Su D
Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
